Figures computed from official regulatory filings — .
Analysttarget 7.4 USD (+61%) · consensus 4.8/5 · 5 buy · 0 hold · 0 sell
Ownershipinsiders 2.14% · institutions 77.85% · short 9.3% of float
In USD · as of Oct 5, 2026
Ask the machine
Search and compare insider transactions, companies and their statistics in plain language. Your question becomes a query over available data, not a conversation or investment advice.
Data for MIMEDX GROUP, INC. only. No web search. Global per-insider statistics are excluded.
An executed search uses one credit, even with no results. Errors and unsupported questions use no credits.
MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. The company processes the human placental tissues membrane, and umbilical cord and the placental disc utilizing its patented and proprietary PURION process to produce allografts that retains the tissue's inherent biological properties and regulatory proteins, including cytokines, chemokines, and growth factors. Its patented and proprietary processing method employs aseptic processing techniques in addition to terminal sterilization. The company's wound care products include EPIFIX, EPICORD, EPIXPRESS, CHORIOFIX, EMERGE, CELERA, REGENKIT WOUND GEL, and EPIEFFECT sheets for use as protective barriers that enables a healthcare provider to select an appropriate size graft based on the size of the wound to reduce product waste. Its surgical and other product offerings consist of AMNIOFIX, AMNIOBURN, AMNIOCORD, AXIOFILL, HELIOGEN, and AMNIOEFFECT for applications in a variety of applications and surgical settings, including lower extremity repair, plastic surgery, vascular surgery, and various orthopedic repairs and reconstructions. The company's products are used in the areas of wound care, burn, and surgical fields in healthcare. It sells its products through direct sales force and independent sales agents, as well as to individual customers and independent distributors in the United States. The company has a strategic alliance with Vaporox, Inc. for the promotion of their wound care offerings. The company was founded in 2006 and is headquartered in Marietta, Georgia.
Market information source · Oct 5, 2026
Periods recorded in the consulted sources. These do not certify the legal dates of name changes.
SEC company identity · Oct 5, 2026
Open-market timeline · full history
74 buys117 sells— close pricebar = usd volume, √ scaleclick a period to filter the table
| Maersk-Moller Kimberly | Other | $75.9K | SEC |
| PUHY DOROTHY E | Award | $185.3K | Unusual size | SEC |
| HAWKINS WILLIAM A | Award | $185.3K | SEC |
| Olson Tiffany | Award | $185.3K | Unusual size | SEC |
| Newton Todd | Award | $185.3K | SEC |
| BIERMAN JAMES L | Award | $185.3K | SEC |
| Maersk-Moller Kimberly | Other | $29.6K | SEC |
| Hulse William Frank IV | Other | $88.7K | SEC |
| Hulse William Frank IV | Other | $276.6K | Unusual size | SEC |
| DOUG RICE | Exercise | $1.1M | SEC |
| DOUG RICE | Other | $433.6K | Unusual size | SEC |
| Hulse William Frank IV | Exercise | $613.6K | SEC |
| Maersk-Moller Kimberly | Other | $95.7K | SEC |
| Maersk-Moller Kimberly | Exercise | $192.8K | SEC |
| Whitlow Ricci S | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Maersk-Moller Kimberly | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Hulse William Frank IV | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Maersk-Moller Kimberly | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| DOUG RICE | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Capper Joseph Htrack record | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Hulse William Frank IV | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| DOUG RICE | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Whitlow Ricci S | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Capper Joseph Htrack record | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |